The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Blend Labs Inc (NYSE: BLND) was $3.48 for the day, down -2.52% from the previous closing price of $3.57. In other words, the price has decreased by -$2.52 from its previous closing price. On the day, 1.21 million shares were traded. BLND stock price reached its highest trading level at $3.56 during the session, while it also had its lowest trading level at $3.45.
Ratios:
Our analysis of BLND’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.39 and its Current Ratio is at 2.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on December 18, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $7.
On August 12, 2024, Canaccord Genuity Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $3 to $4.75.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 10 ’25 when Ling Winnie bought 4,000 shares for $3.54 per share.
Kneafsey Brian sold 20,000 shares of BLND for $69,182 on Jul 07 ’25. The Head of Revenue now owns 766,598 shares after completing the transaction at $3.46 per share. On Jul 07 ’25, another insider, Kneafsey Brian, who serves as the Officer of the company, bought 20,000 shares for $3.46 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLND now has a Market Capitalization of 886620480 and an Enterprise Value of 895886592. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.85. Its current Enterprise Value per Revenue stands at 5.431 whereas that against EBITDA is -32.704.
Stock Price History:
The Beta on a monthly basis for BLND is 1.25, which has changed by 0.2428571 over the last 52 weeks, in comparison to a change of 0.11844492 over the same period for the S&P500. Over the past 52 weeks, BLND has reached a high of $5.53, while it has fallen to a 52-week low of $2.29. The 50-Day Moving Average of the stock is 0.61%, while the 200-Day Moving Average is calculated to be -7.84%.
Shares Statistics:
BLND traded an average of 2.27M shares per day over the past three months and 1853690 shares per day over the past ten days. A total of 255.08M shares are outstanding, with a floating share count of 203.47M. Insiders hold about 21.30% of the company’s shares, while institutions hold 47.75% stake in the company. Shares short for BLND as of 1749772800 were 7898628 with a Short Ratio of 3.48, compared to 1747267200 on 7833637. Therefore, it implies a Short% of Shares Outstanding of 7898628 and a Short% of Float of 3.39.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 5.0 analysts. The consensus estimate for the next quarter is $0.02, with high estimates of $0.02 and low estimates of $0.01.
Analysts are recommending an EPS of between $0.07 and $0.03 for the fiscal current year, implying an average EPS of $0.05. EPS for the following year is $0.13, with 5.0 analysts recommending between $0.16 and $0.08.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 7 analysts. It ranges from a high estimate of $34.15M to a low estimate of $30.9M. As of the current estimate, Blend Labs Inc’s year-ago sales were $40.48MFor the next quarter, 7 analysts are estimating revenue of $36.71M. There is a high estimate of $38.17M for the next quarter, whereas the lowest estimate is $35.43M.
A total of 7 analysts have provided revenue estimates for BLND’s current fiscal year. The highest revenue estimate was $135.07M, while the lowest revenue estimate was $128.08M, resulting in an average revenue estimate of $132M. In the same quarter a year ago, actual revenue was $162.02MBased on 7 analysts’ estimates, the company’s revenue will be $169.72M in the next fiscal year. The high estimate is $177.97M and the low estimate is $150.3M.
